Company intelligence / Profile preview
Argonaute RNA
Bristol/Cardiff, England/Wales, United Kingdomargonauterna.com ↗
- Ownership
- Private
- Employees
- ~7
- Development stage
- Preclinical
01
Overview
Argonaute RNA develops proprietary dual-siRNA therapeutics using its PULSE siRNA™ platform, enabling simultaneous silencing of two genes. The approach aims to address complex, multifactorial diseases where targeting a single gene may be insufficient. Their technology focuses on safe, effective, and temporary gene silencing with improved stability over traditional siRNAs. The company has deep industry expertise in taking programs from early-stage through Phase II trials but current pipeline details suggest preclinical/IND-enabling status for most assets.
- Therapeutic areas
- OncologyCardiovascularRare Diseases
- Modalities
- small interfering RNAs (siRNA)dual siRNA constructs
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
CatSci – collaboration for manufacturing high-quality siRNA drug substance for robust preclinical studies and scale-up for clinical trials.Carbometrics – partnership to enhance bioconjugation/synthetic chemistry aspects of the platform.
Beyond the preview
Go deeper on Argonaute RNA.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Argonaute RNA.